3,6-Di(2-thienyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione>95.0%(HPLC)(N)5g

4-Methylnicotinic acid, 97.0%, 10g

2-(3-Methoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

Sphos, minimo 98%, 5 g, confezione in vetro

4-Chloro-6-methoxypyridin-2-amine, 97%, 1g

3-Chloro-2,6-pyridinediamine, 95+%, 1g

3-Cyclopentylisoxazole-4-carboxylic acid, 95%, 500mg

3,3'-Oxydianiline, 97%, 10g

(2E)-1-(4-ethoxyphenyl)-3-(5-methylfuran-2-yl)prop-2-en-1-one, 95.0%, 2g

NUTLIN-3B, 95%, 50mg

N-(3-Dimethylaminopropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 250mg

Nonanal>95.0%(GC)500mL

2,6-Dichloro-isonicotinic acid N'-(2,6-dichloro-pyridine-4-carbonyl)-hydrazide, 95.0%, 1g